| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.34▲ | 9.48▼ | 9.57▼ | 10.10▼ | 11.61▼ |
| MA10 | 9.40▼ | 9.58▼ | 9.90▼ | 10.55▼ | 13.56▼ |
| MA20 | 9.48▼ | 9.96▼ | 10.22▼ | 11.89▼ | 12.45▼ |
| MA50 | 9.59▼ | 10.34▼ | 10.60▼ | 14.11▼ | 7.48▲ |
| MA100 | 9.90▼ | 10.64▼ | 11.11▼ | 12.41▼ | 6.77▲ |
| MA200 | 10.24▼ | 11.31▼ | 13.32▼ | 8.56▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.045▼ | -0.094▼ | -0.160▼ | -0.786▼ |
| RSI | 38.614▼ | 22.227▼ | 18.737▼ | 22.632▼ | 44.529▼ |
| STOCH | 22.008 | 8.925▼ | 5.834▼ | 11.292▼ | 15.317▼ |
| WILL %R | -61.194 | -87.500▼ | -91.096▼ | -96.232▼ | -99.092▼ |
| CCI | -48.844 | -127.753▼ | -110.376▼ | -213.895▼ | -131.146▼ |
|
Monday, September 21, 2026 06:16 AM
Q32 Bio Inc. (Nasdaq: QTTB) announced it will present results from Part B of its SIGNAL-AA Phase 2a clinical trial evaluating bempikibart in patients with severe or ...
|
|
Monday, September 21, 2026 06:16 AM
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical-stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, to ...
|
|
Wednesday, May 27, 2026 05:00 PM
Q32 Bio raised approximately $55 million in a private placement led by major healthcare investors as the company continues development of its Phase 2 alopecia areata therapy program. ・Q32 Bio ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/09/26 | 9.475 | 9.49 | 9.25 | 9.38 | 83,575 |
| 23/09/26 | 10.58 | 10.58 | 9.50 | 9.56 | 825,140 |
| 22/09/26 | 10.60 | 10.99 | 10.531 | 10.57 | 385,854 |
| 21/09/26 | 10.57 | 10.75 | 10.30 | 10.47 | 358,710 |
| 18/09/26 | 10.84 | 10.97 | 10.46 | 10.54 | 972,313 |
| 17/09/26 | 11.14 | 11.165 | 10.69 | 10.86 | 383,868 |
| 16/09/26 | 11.17 | 11.4124 | 10.87 | 10.98 | 502,731 |
| 15/09/26 | 10.77 | 11.29 | 10.51 | 11.17 | 602,293 |
| 14/09/26 | 10.96 | 11.28 | 10.63 | 10.91 | 870,605 |
| 11/09/26 | 10.82 | 11.27 | 10.45 | 11.10 | 1,824,217 |
|
|
||||
|
|
||||
|
|